Wicab

Focus: Wicab is a Wisconsin-based medical device company specializing in sensory substitution technology, operating at mid-scale with 1,001–5,000 employees since 1998. The company develops neurotechnology devices that enable sensory perception through alternative neural pathways, addressing blindness and vestibular disorders.

Profile data last refreshed 16h ago · AI intelligence enriched 3w ago

Funding Stage

PUBLIC

Employees

1001-5000

Open Jobs

About Wicab

AI assessmentNot Hiring

No open roles listed right now. Follow Wicab to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

7 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

BrainPort V200 Device

Blindness

N/A

Training with the BrainPort balance device

Vestibular Diseases

N/A

Clinical Trials (1)

Help build intelligence for Wicab

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Deep technical specialization in neurotechnology and sensory substitution—a rare, defensible niche with limited competitors.
Established public company with 25+ years of history and a portfolio of FDA-cleared or clinical-stage devices addressing high-unmet-need conditions (blindness, balance disorders).
Opportunity to work on breakthrough sensory restoration technologies that directly improve quality of life for blind and vestibular-impaired patients.

Watch Out For

Zero active job openings at time of data capture suggests limited near-term hiring; potential organizational stability concerns or restructuring phase.
Sparse pipeline activity (6 total trials, all early/non-IND stage) and minimal published science (5 publications) indicate slower R&D momentum than peers and limited near-term catalysts.

Generated by Claude from Wicab's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

NCT00768378Safety and Efficacy Study of BrainPort® Balance Device in Peripheral Vestibular Dysfunction.

N/A

BrainPort Vision Device

Blindness

N/A

Clinical Trials (1)

NCT01488786A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind

N/A

electronic Vision-aid Device

the Blind

N/A

Clinical Trials (1)

NCT05968365Evaluate the Safety and Effectiveness of Electronic Vision-aid Device

N/A

Electrotactile sensory substitution

Vestibular Disease

N/A

Clinical Trials (1)

NCT00254228Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction

N/A

BrainPort Vision Pro

Blindness

N/A

Clinical Trials (1)

NCT04725760Evaluation of the Efficacy of the BrainPort Vision Pro on the Performance of Daily Activities in the Profoundly Blind French Population

N/A

BrainPort Balance Device

Cerebrovascular Accident

N/A

Clinical Trials (1)

NCT00567944Use of the BrainPort® Balance Device to Improve Balance in Adults With Balance Deficits Due to Stroke

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 1998

Portfolio: 6 clinical trials

Publications: 5 in PubMed

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Research Publications(5)

Recent peer-reviewed publications with author affiliations at this company

Education Reform using Common Career Selective Programme (CCSP) to Promote Education-for-All (EFA).

F1000Research

2025

PMID:41458392

Performance of Real-world Functional Tasks Using an Updated Oral Electronic Vision Device in Persons Blinded by Trauma.

Optometry and vision science : official publication of the American Academy of Optometry

2018

PMID:30169354